Nancy Dreyer is Global Chief of Scientific Affairs for Quintiles’ Real-World and Late Phase Research, where she leads an international team in the design, conduct, and interpretation of “real-world” health research, including effectiveness, safety, quality improvement activities and sports injuries. She is a senior editor of “Registries for Evaluating Patient Outcomes: A User’s Guide,” now in its third edition and also leads the GRACE Initiative for developing Good Research Practices for Observational Studies of Comparative Effectiveness (www.graceprinciples.org). She is a member of the U.S. Food & Drug Administration’s National Medical Device Postmarket Surveillance System Planning Board, a co-lead investigator for a study on developing new methodologies for pharmacovigilance in collaboration with the European Medicines Agency, and is an advisor to the Center of Post-Marketing Safety Evaluation at Peking University. In addition to her work at Quintiles, Dreyer is an Adjunct Professor of Epidemiology at the UNC-Chapel Hill.
Prior to joining Quintiles, Dr. Dreyer served as Senior Vice President with United Health Group/i3 where she focused on traditional drug safety as well as in clinical trials and outcomes research. Dr. Dreyer earned her AB degree in Sociology from Brandeis University and her MPH and PhD in Epidemiology from the University of North Carolina at Chapel Hill.